Hanwang Technology is among the participants in a $15.8m round for the genetic testing services provider, which has now raised $23m in total.
China-based genetic testing provider 23Mofang has raised RMB100m ($15.8m) from a consortium including mobile-input technology producer Hanwang Technology, DealStreetAsia has reported.
The deal was led by venture capital firm Matrix Partners China and also featured ZhenFund as well as Yahui Medical Fund.
Founded in 2015, 23Mofang offers genetic testing services for individuals through a mobile app. The service has more than 150,000 users and includes tests for health risks and rare genetic diseases, as well as conditions particularly…
